nach oben

Erschienen in:

26.05.2016 | Original Communication

Subcortical matter in the α-synucleinopathies spectrum: an MRI pilot study

verfasst von: S. Gazzina, E. Premi, R. Turrone, J. Acosta-Cabronero, M. C. Rizzetti, M. S. Cotelli, R. Gasparotti, A. Padovani, B. Borroni

Erschienen in: Journal of Neurology | Ausgabe 8/2016

Einloggen, um Zugang zu erhalten

Abstract

α-Synucleinopathies, such as Parkinson’s disease (PD) and dementia with Lewy bodies (DLB), are characterized by α-synuclein accumulation from brainstem structures to the neocortex. PD and DLB are clinically distinguishable, while discrimination between Parkinson Disease Dementia (PDD) and DLB can be subtle and based on the temporal relationship between motor and cognitive symptoms. To explore patterns of subcortical atrophy in PD, PDD and DLB, and assess specific differences between PD and PDD, and between DLB and PDD. 16 PD, 11 PDD and 16 DLB patients were recruited and underwent 1.5 Tesla structural MRI scanning. Segmentation of subcortical structures was performed with a well-validated, fully-automated tool, and volume and shape for each structure were compared between groups. PDD and DLB patients showed global subcortical atrophy compared to PD patients. Greater hippocampal atrophy was the specific trait that distinguished PDD from PD, while greater atrophy of the pallidi discriminated DLB from PDD. Vertex analysis revealed specific shape differences in both structures. Our results suggest that automated, time-sparing, subcortical volumetry may provide diagnostically useful information in α-synucleinopathies. Future studies on larger samples and with iron-sensitive MRI contrasts are needed.

Braak H, Del Tredici K, Rub U, de Vos RA, Jansen Steur EN, Braak E (2003) Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiol Aging 24:197–211CrossRefPubMed

Emre M (2003) Dementia associated with Parkinson’s disease. Lancet Neurol 2:229–237CrossRefPubMed

Hurtig HI, Trojanowski JQ, Galvin J et al (2000) Alpha-synuclein cortical Lewy bodies correlate with dementia in Parkinson’s disease. Neurology. 54:1916–1921CrossRefPubMed

McKeith IG, Dickson DW, Lowe J et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 65:1863–1872CrossRefPubMed

Tsuboi Y, Dickson DW (2005) Dementia with Lewy bodies and Parkinson’s disease with dementia: are they different? Parkinsonism Relat Disord. 11(Suppl 1):S47–51CrossRefPubMed

Guo L, Itaya M, Takanashi M, Mizuno Y, Mori H (2005) Relationship between Parkinson disease with dementia and dementia with Lewy bodies. Parkinsonism Relat Disord. 11:305–309CrossRefPubMed

Goldman JG, Williams-Gray C, Barker RA, Duda JE, Galvin JE (2014) The spectrum of cognitive impairment in Lewy body diseases. Mov Disord 29:608–621CrossRefPubMedPubMedCentral

Aarsland D, Ballard CG, Halliday G (2004) Are Parkinson’s disease with dementia and dementia with Lewy bodies the same entity? J Geriatr Psychiatry Neurol 17:137–145CrossRefPubMed

Beyer MK, Larsen JP, Aarsland D (2007) Gray matter atrophy in Parkinson disease with dementia and dementia with Lewy bodies. Neurology. 69:747–754CrossRefPubMed

10.

Borroni B, Premi E, Formenti A et al (2015) Structural and functional imaging study in dementia with Lewy bodies and Parkinson’s disease dementia. Parkinsonism Relat Disord. 21:1049–1055CrossRefPubMed

11.

Planetta PJ, Kurani AS, Shukla P et al (2015) Distinct functional and macrostructural brain changes in Parkinson’s disease and multiple system atrophy. Hum Brain Mapp 36:1165–1179CrossRefPubMed

12.

Menke RA, Szewczyk-Krolikowski K, Jbabdi S et al (2014) Comprehensive morphometry of subcortical grey matter structures in early-stage Parkinson’s disease. Hum Brain Mapp 35:1681–1690CrossRefPubMed

13.

Garg A, Appel-Cresswell S, Popuri K, McKeown MJ, Beg MF (2015) Morphological alterations in the caudate, putamen, pallidum, and thalamus in Parkinson’s disease. Front Neurosci. 9:101CrossRefPubMedPubMedCentral

14.

Sterling NW, Du G, Lewis MM et al (2013) Striatal shape in Parkinson’s disease. Neurobiol Aging 34:2510–2516CrossRefPubMedPubMedCentral

15.

Nemmi F, Sabatini U, Rascol O, Peran P (2015) Parkinson’s disease and local atrophy in subcortical nuclei: insight from shape analysis. Neurobiol Aging 36:424–433CrossRefPubMed

16.

Lee HM, Kwon KY, Kim MJ et al (2014) Subcortical grey matter changes in untreated, early stage Parkinson’s disease without dementia. Parkinsonism Relat Disord. 20:622–626CrossRefPubMed

17.

Melzer TR, Watts R, MacAskill MR et al (2012) Grey matter atrophy in cognitively impaired Parkinson’s disease. J Neurol Neurosurg Psychiatry 83:188–194CrossRefPubMed

18.

Mak E, Bergsland N, Dwyer MG, Zivadinov R, Kandiah N (2014) Subcortical atrophy is associated with cognitive impairment in mild Parkinson disease: a combined investigation of volumetric changes, cortical thickness, and vertex-based shape analysis. AJNR Am J Neuroradiol 35:2257–2264CrossRefPubMed

19.

Pereira JB, Junque C, Bartres-Faz D, Ramirez-Ruiz B, Marti MJ, Tolosa E (2013) Regional vulnerability of hippocampal subfields and memory deficits in Parkinson’s disease. Hippocampus. 23:720–728CrossRefPubMed

20.

Apostolova LG, Beyer M, Green AE et al (2010) Hippocampal, caudate, and ventricular changes in Parkinson’s disease with and without dementia. Mov Disord 25:687–695CrossRefPubMedPubMedCentral

21.

Mak E, Su L, Williams GB, O’Brien JT (2015) Neuroimaging correlates of cognitive impairment and dementia in Parkinson’s disease. Parkinsonism Relat Disord. 21:862–870CrossRefPubMed

22.

Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184CrossRefPubMedPubMedCentral

23.

Emre M, Aarsland D, Brown R et al (2007) Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord 22:1689–1707CrossRefPubMed

24.

Goetz CG, Emre M, Dubois B (2008) Parkinson’s disease dementia: definitions, guidelines, and research perspectives in diagnosis. Ann Neurol. 64(Suppl 2):S81–92PubMed

25.

Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, Gornbein J (1994) The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 44:2308–2314CrossRefPubMed

26.

Lezak MD (1995) Neuropsychological assessment, 3rd edn. Oxford University Press, New York

27.

van Norden AG, Fick WF, de Laat KF et al (2008) Subjective cognitive failures and hippocampal volume in elderly with white matter lesions. Neurology. 71:1152–1159CrossRefPubMed

28.

Patenaude B, Smith SM, Kennedy DN, Jenkinson M (2011) A Bayesian model of shape and appearance for subcortical brain segmentation. Neuroimage. 56:907–922CrossRefPubMedPubMedCentral

29.

Taylor CJ, Cootes TF, Lanitis A, Edwards G, Smyth P, Kotcheff AC (1997) Model-based interpretation of complex and variable images. Philos Trans R Soc Lond B Biol Sci 352:1267–1274CrossRefPubMedPubMedCentral

30.

Sandman CA, Head K, Muftuler LT, Su L, Buss C, Davis EP (2014) Shape of the basal ganglia in preadolescent children is associated with cognitive performance. Neuroimage. 99:93–102CrossRefPubMed

31.

Genovese CR, Lazar NA, Nichols T (2002) Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage. 15:870–878CrossRefPubMed

32.

Berg D, Postuma RB, Bloem B et al (2014) Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson’s disease. Mov Disord 29:454–462CrossRefPubMedPubMedCentral

33.

Tsuboi Y, Uchikado H, Dickson DW (2007) Neuropathology of Parkinson’s disease dementia and dementia with Lewy bodies with reference to striatal pathology. Parkinsonism Relat Disord. 13(Suppl 3):S221–224CrossRefPubMed

34.

Jellinger KA, Attems J (2006) Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies? Acta Neuropathol 112:253–260CrossRefPubMed

35.

Morey RA, Petty CM, Xu Y et al (2009) A comparison of automated segmentation and manual tracing for quantifying hippocampal and amygdala volumes. Neuroimage. 45:855–866CrossRefPubMed

36.

Morey RA, Selgrade ES, Wagner HR 2nd, Huettel SA, Wang L, McCarthy G (2010) Scan-rescan reliability of subcortical brain volumes derived from automated segmentation. Hum Brain Mapp 31:1751–1762PubMedPubMedCentral

37.

Nugent AC, Luckenbaugh DA, Wood SE, Bogers W, Zarate CA Jr, Drevets WC (2013) Automated subcortical segmentation using FIRST: test-retest reliability, interscanner reliability, and comparison to manual segmentation. Hum Brain Mapp 34:2313–2329CrossRefPubMed

38.

Ruffmann C, Calboli FC, Bravi I et al (2015) Cortical Lewy bodies and Abeta burden are associated with prevalence and timing of dementia in Lewy body diseases. Neuropathol Appl Neurobiol. doi:10.1111/nan.12294

39.

Hegeman DJ, Hong ES, Hernandez VM, Chan SC (2016) The external globus pallidus: progress and perspectives. Eur J Neurosci 43(10):1239–1265CrossRefPubMed

40.

Gittis AH, Berke JD, Bevan MD et al (2014) New roles for the external globus pallidus in basal ganglia circuits and behavior. J Neurosci 34:15178–15183CrossRefPubMedPubMedCentral

41.

Acosta-Cabronero J, Betts MJ, Cardenas-Blanco A, Yang S, Nestor PJ (2016) In Vivo MRI mapping of brain iron deposition across the adult lifespan. J Neurosci 36:364–374CrossRefPubMedPubMedCentral

42.

Goto M, Abe O, Miyati T et al (2013) Association between iron content and gray matter missegmentation with voxel-based morphometry in basal ganglia. J Magn Reson Imaging 38:958–962CrossRefPubMed

Titel: Subcortical matter in the α-synucleinopathies spectrum: an MRI pilot study
verfasst von: S. Gazzina
E. Premi
R. Turrone
J. Acosta-Cabronero
M. C. Rizzetti
M. S. Cotelli
R. Gasparotti
A. Padovani
B. Borroni
Publikationsdatum: 26.05.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Neurology / Ausgabe 8/2016
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-016-8173-5

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

25.04.2024 | Hypotonie | Nachrichten

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Subcortical matter in the α-synucleinopathies spectrum: an MRI pilot study

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2016

PROSPERA: a randomized, controlled trial evaluating rasagiline in progressive supranuclear palsy

Safety and efficacy of dimethyl fumarate in multiple sclerosis: a multi-center observational study

Heterogeneity in clinical features and disease severity in ataxia-associated SYNE1 mutations

Alterations of functional and structural connectivity of freezing of gait in Parkinson’s disease

Relapse frequency in transitioning from natalizumab to dimethyl fumarate: assessment of risk factors

The role of polymyography in the treatment of cervical dystonia: the authors reply

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Demenzkranke durch Antipsychotika vielfach gefährdet

Parkinson-Therapie im Wandel – aktuelle Leitlinie im Fokus

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

Update Neurologie